Integrated Development And Manufacturing At Flamma's Chignolo Headquarters

Located near Milan, the Chignolo d’Isola site anchors an integrated approach to small‑molecule API development and manufacturing, supporting programs from early research through commercial scale‑up. A combination of cGMP pilot plant operations and large‑scale production allows processes to be evaluated, optimized, and transferred with continuity and control. Strong in‑house expertise in solid‑state chemistry, crystallization, and risk assessment helps improve robustness and reproducibility while reducing technical and safety risks as projects advance.

The facility is equipped to manage complex chemistries and potent compounds, with advanced containment systems, filter dryers, centrifuges, and powder handling technologies designed to protect personnel and maintain product quality. Continuous investment has expanded R&D capacity and strengthened analytical, process safety, and flow chemistry capabilities. FDA and AIFA inspections further reinforce regulatory readiness for global programs. Together, these capabilities create a streamlined pathway for moving molecules efficiently from laboratory development into reliable clinical and commercial supply.

Unveil the full brochure to see how this integrated platform supports faster, safer progress across development stages.